【24h】

Connecting the Cs: Coronaries, Creatinine, Compliance, CRUSADE

机译:连接Cs:冠状动脉,肌酐,法规遵从性,CRUSADE

获取原文
获取原文并翻译 | 示例
           

摘要

Chronic kidney disease (CKD) is highly prevalent in the United States, affecting 1 in 6 individuals over the age of 20. Left untreated, CKD can result in end-stage renal disease (ESRD) necessitating either hemodialysis or kidney transplantation. The National Kidney Foundation (NKF), along with the American College of Cardiology (ACC) and the American Heart Association (AHA), recognize CKD as a coronary heart disease (CHD) risk equivalent. Many of the risk factors for CKD, such as diabetes, hypertension, and obesity, also underlie coronary artery disease (CAD). Therefore, it should not be surprising that CAD is highly prevalent among CKD patients and accounts for significant morbidity and mortality. Furthermore, the risk of cardiovascular events, including mortality, correlate with the severity of the CKD.4'8 These findings underlie the importance of aggressively diagnosing and treating CAD in patients with CKD.
机译:慢性肾脏病(CKD)在美国非常普遍,影响20岁以上的6个人中的1个人。如果不加以治疗,CKD可能导致终末期肾脏病(ESRD),需要进行血液透析或肾脏移植。美国国家肾脏基金会(NKF),美国心脏病学会(ACC)和美国心脏协会(AHA)均将CKD视为与冠心病(CHD)风险相当的疾病。 CKD的许多危险因素,例如糖尿病,高血压和肥胖症,也是冠状动脉疾病(CAD)的基础。因此,CAD在CKD患者中非常普遍并且占显着的发病率和死亡率并不奇怪。此外,包括死亡在内的心血管事件的风险与CKD的严重程度相关。4'8这些发现奠定了积极诊断和治疗CKD患者CAD的重要性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号